Molecular Dx Reimbursement: Medicare Contractor Seeks Tighter Controls
This article was originally published in The Gray Sheet
Executive Summary
The Medicare contractor that handles claims for California and several other states is taking steps to enhance its control over reimbursement of molecular diagnostic tests.